JM Search raised $56M for jumping-gene tech, in vivo CAR-T.
Public source
Publisher name
Public post
Sharing this exciting news. Typewriter is advancing a potentially transformative approach for patients with devastating immunological diseases who have not been adequate…
Company
JM Search
The leading retained executive search firm for private equity, and other growth-oriented organizations.
- Industry
- Executive Search Services
- Location
- King of Prussia, US
- Company size
- 201–500 employees
About JM Search
JM Search is the leading retained executive search firm for private equity, and other growth-oriented private and public organizations. With over 40 years of experience, our partners are immersed in your search every step of the way, supported by a passionate, cohesive team of recruiting experts. With deep sector and functional-specific expertise, our partners have built expansive professional networks from decades of firsthand experience to ensure the best possible outcomes for our clients and their businesses. One firm, focused on you.®
See moreLatest activity
Latest activity from JM Search
19 signals
Research & Knowledge
JM Search colleagues published several insights on the most common trends in their Go-to-Market searches regarding commercial leadership.
Research & Knowledge
JM Search colleague Kristian Shannon offers a thoughtful look at the evolution of AI in executive search with Hunt Scanlon Media.
People
JM Search is honored to partner and welcomes nominations for the James Barry-Robinson Institute's next Chief Executive Officer position.
Discover more
Similar signals
Similar public activity from other companies.
Capital & Finance
Typewriter Therapeutics, Inc.
Typewriter Therapeutics, Inc. has emerged from stealth with $56 million in Series A financing led by AN Venture Partners and RA Capital Management, with participation from ANRI, Gemseki, and SBI US Gateway Fund.
Capital & Finance
bioSeedin
bioSeedin reported that NovaGo Therapeutics raised $30 million in a round led by Neurimmune and Pureos for $30 million.
Capital & Finance
Collabrity
Collabrity reported that Typewriter announced a $56 Million Series A financing.
Capital & Finance
ERAPS - Executive Regulatory Affairs Professional Search
ERAPS - Executive Regulatory Affairs Professional Search announced that Menarini signed a $771M deal to take Gan & Lee GLP-1 to the European market.
Capital & Finance
biotalent.ai